94 related articles for article (PubMed ID: 24638068)
41. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
42. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
[TBL] [Abstract][Full Text] [Related]
43. MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo.
Cavalli G; Hayashi M; Jin Y; Yorgov D; Santorico SA; Holcomb C; Rastrou M; Erlich H; Tengesdal IW; Dagna L; Neff CP; Palmer BE; Spritz RA; Dinarello CA
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1363-8. PubMed ID: 26787888
[TBL] [Abstract][Full Text] [Related]
44. Abnormal association between invariant chain and HLA class II alpha and beta chains in chronic lymphocytic leukemia.
Veenstra H; Jacobs P; Dowdle EB
Cell Immunol; 1996 Jul; 171(1):68-73. PubMed ID: 8660839
[TBL] [Abstract][Full Text] [Related]
45. Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome.
Fortin JS; Cloutier M; Thibodeau J
Front Immunol; 2013 Dec; 4():443. PubMed ID: 24379812
[TBL] [Abstract][Full Text] [Related]
46. Interaction of HLA-DR and CD74 at the cell surface of antigen-presenting cells by single particle image analysis.
Karakikes I; Morrison IE; O'Toole P; Metodieva G; Navarrete CV; Gomez J; Miranda-Sayago JM; Cherry RJ; Metodiev M; Fernandez N
FASEB J; 2012 Dec; 26(12):4886-96. PubMed ID: 22889831
[TBL] [Abstract][Full Text] [Related]
47. Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus.
Lamb CA; Yewdell JW; Bennink JR; Cresswell P
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):5998-6002. PubMed ID: 2068076
[TBL] [Abstract][Full Text] [Related]
48. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
[TBL] [Abstract][Full Text] [Related]
49. HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains.
Rich T; Lawler SE; Lord JM; Blancheteau VM; Charron DJ; Mooney NA
J Immunol; 1997 Oct; 159(8):3792-8. PubMed ID: 9378966
[TBL] [Abstract][Full Text] [Related]
50. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments.
Anderson HA; Bergstralh DT; Kawamura T; Blauvelt A; Roche PA
J Immunol; 1999 Nov; 163(10):5435-43. PubMed ID: 10553069
[TBL] [Abstract][Full Text] [Related]
51. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
Momburg F; Koretz K; Von Herbay A; Möller P
Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
[TBL] [Abstract][Full Text] [Related]
52. Invariant chain increases the half-life of MHC II by delaying endosomal maturation.
Landsverk OJ; Barois N; Gregers TF; Bakke O
Immunol Cell Biol; 2011 Jul; 89(5):619-29. PubMed ID: 21116285
[TBL] [Abstract][Full Text] [Related]
53. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
Malcherek G; Wirblich C; Willcox N; Rammensee HG; Trowsdale J; Melms A
Eur J Immunol; 1998 May; 28(5):1524-33. PubMed ID: 9603457
[TBL] [Abstract][Full Text] [Related]
54. The production of recombinant HLA-DR beta and invariant chain polypeptides by cDNA expression in E. coli.
Koch S; Schultz A; Koch N
J Immunol Methods; 1987 Nov; 103(2):211-20. PubMed ID: 3312416
[TBL] [Abstract][Full Text] [Related]
55. The active translation of MHCII mRNA during dendritic cells maturation supplies new molecules to the cell surface pool.
Malanga D; Barba P; Harris PE; Maffei A; Del Pozzo G
Cell Immunol; 2007 Apr; 246(2):75-80. PubMed ID: 17662701
[TBL] [Abstract][Full Text] [Related]
56. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
Demotz S
Eur J Immunol; 1993 Sep; 23(9):2100-8. PubMed ID: 8370392
[TBL] [Abstract][Full Text] [Related]
57. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing.
Bellemare-Pelletier A; Tremblay J; Beaulieu S; Boulassel MR; Routy JP; Massie B; Lapointe R; Thibodeau J
J Leukoc Biol; 2005 Jul; 78(1):95-105. PubMed ID: 15817706
[TBL] [Abstract][Full Text] [Related]
58. A splice acceptor variant in HLA-DRA affects the conformation and cellular localization of the class II DR alpha-chain.
Didonna A; Damotte V; Shams H; Matsunaga A; Caillier SJ; Dandekar R; Misra MK; Mofrad MRK; Oksenberg JR; Hollenbach JA
Immunology; 2021 Feb; 162(2):194-207. PubMed ID: 32986852
[TBL] [Abstract][Full Text] [Related]
59. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain.
Strubin M; Berte C; Mach B
EMBO J; 1986 Dec; 5(13):3483-8. PubMed ID: 3104027
[TBL] [Abstract][Full Text] [Related]
60. Structural requirements for recognition of major histocompatibility complex class II by membrane-associated RING-CH (MARCH) protein E3 ligases.
Jahnke M; Trowsdale J; Kelly AP
J Biol Chem; 2012 Aug; 287(34):28779-89. PubMed ID: 22761441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
